N‑Phenyl‑4‑piperidinamine Added to Schedule VI

Summary#

This is the Order Amending Schedule VI to the Controlled Drugs and Substances Act (Novel Fentanyl Precursors). It replaces one entry in Schedule VI to add N-Phenyl-4-piperidinamine and certain related chemicals to the list. The order comes into force on August 30, 2023.

What it does#

• Replaces Item 30 in Part 1 of Schedule VI to the Controlled Drugs and Substances Act with a new description that covers:
  • N-Phenyl-4-piperidinamine (also called N-phenylpiperidin-4-amine), and
  • its salts, derivatives and analogues, and salts of those derivatives and analogues.
• Explicitly lists several example compounds included under that description, such as:
  • 4-anilino-1-boc-piperidine (tert-butyl 4-(phenylamino)piperidine-1-carboxylate),
  • 4-fluoro anilino-1-boc-piperidine (tert-butyl 4-((4-fluorophenyl)amino)piperidine-1-carboxylate),
  • N-(4-fluorophenyl)-4-piperidinamine (N-(4-fluorophenyl)piperidin-4-amine),
  • 4-bromo anilino-1-boc-piperidine (tert-butyl 4-((4-bromophenyl)amino)piperidine-1-carboxylate).
• Sets the effective date as August 30, 2023.

Who's affected#

• Companies and people who make, sell, import, export or handle the listed chemicals and their close chemical relatives.
• Laboratories and researchers that use these substances in legitimate research or manufacturing.
• Law enforcement and border agencies involved in tracking and stopping illegal drug supply chains.
• It will also affect people involved in illegal fentanyl production, since the listed substances are associated with fentanyl synthesis.

Why it matters#

• The listed chemicals are connected to fentanyl production. Adding them to Schedule VI brings them under federal precursor controls.
• That can make it harder for illegal producers to get these ingredients.
• At the same time, legitimate suppliers and researchers may face new paperwork, restrictions, or the need to get permits or licences. The order text does not detail specific compliance steps or penalties.